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The bacteria of the Brucella genus are responsible for a worldwide zoonosis called brucellosis. They belong to the
-proteobacteria group, as many other bacteria that live in close association with a eukaryotic host. Importantly, the
Brucellae are mainly intracellular pathogens, and the molecular mechanisms of their virulence are still poorly
understood. Using the complete genome sequence of Brucella melitensis, we generated a database of protein-coding
open reading frames (ORFs) and constructed an ORFeome library of 3091 Gateway Entry clones, each containing a
defined ORF. This first version of the Brucella ORFeome (v1.1) provides the coding sequences in a user-friendly format
amenable to high-throughput functional genomic and proteomic experiments, as the ORFs are conveniently
transferable from the Entry clones to various Expression vectors by recombinational cloning. The cloning of the
Brucella ORFeome v1.1 should help to provide a better understanding of the molecular mechanisms of virulence,
including the identification of bacterial protein–protein interactions, but also interactions between bacterial effectors
and their host’s targets.
[The following individuals kindly provided reagents, samples, or unpublished information as indicated in the paper:
C. Baldwin and R. Goenka. The Open Biosystems company will act as a distributor of the Brucella ORFeome clones.]
The -subdivision of Proteobacteria (or purple bacteria) is of fun-
damental biological relevance because it contains not only free-
living organisms (e.g., Rhodobacter and Caulobacter), but also
other members displaying a wide range of associations with eu-
karyotic organisms. These include (1) Agrobacterium, an extracel-
lular plant pathogen that transforms its host by integrating its
T-DNA into the plant’s genome, (2) Rhizobium and related spe-
cies, which are nitrogen-fixing symbionts of legumes, (3) Rickett-
sia, which live as obligate intracellular pathogens of man, but
also insects, (4) Wolbachia, which are intracellular symbionts of
insects, and finally, (5) Bartonella and Brucella, which are facul-
tative intracellular pathogens of mammals. Considering their
tendency to form close, if not intracellular associations with eu-
karyotic cells, it is not surprising that these bacteria developed a
subtle expertise in manipulating or subverting their host’s cellu-
lar processes. However, most of the strategies they exploit are still
to be discovered at the molecular level. Brucella does not make
exception to this rule.
Brucella sp., the etiological agents of brucellosis, have sig-
nificant impact on both livestock and human health worldwide.
In livestock, infection is primarily associated with abortion and
infertility, whereas in man it often results in a chronic, debilitat-
ing disease known as brucellosis or undulant fever (Acha and
Szyfres 1989). Treatment is difficult and prolonged, largely as a
result of the intracellular nature of this pathogen (Young 1989).
Although live attenuated vaccines played a crucial role in suc-
cessful eradication programs (B. abortus strain 19 and B. melitensis
Rev 1), these vaccines remain virulent for man (Spink et al. 1962).
To date, no safe, effective vaccine is available for use in humans.
Brucella is also considered as a potential agent of biological war-
fare or terrorist threat, largely as a result of its chronic debilitating
clinical course, problematic treatment, and lack of suitable vac-
cines (Christopher et al. 1997; Franz et al. 1997).
Chronic intracellular persistence has been postulated as the
reason why mammalian hosts can remain infected for life (En-
right 1990). The understanding of virulence mechanisms used by
Brucella remains sketchy. The chronic nature of brucellosis is
likely to be multifactorial, utilizing both the ability of Brucella to
evade immune detection and adaptation to intracellular survival
inside both phagocytic and nonphagocytic cells. This strategy
involves the inhibition of the phagosomal–lysosomal matura-
tion pathway and the deviation of intracellular trafficking, which
allows the bacterium to reach its endoplasmic reticulum-derived
replicative niche (Celli et al. 2003). The type IV secretion system
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of Brucella (called VirB) plays a key role in this “vacuolar-jacking”
(O’Callaghan et al. 1999; Delrue et al. 2001). Effectors of the VirB
system are thought to interfere with presently unidentified eu-
karyotic targets.
Recently, the genome sequences of two Brucella species
(DelVecchio et al. 2002a; Paulsen et al. 2002) and preliminary
data from a third one became available. Comparative genomics
provide insights into aspects of Brucella virulence that were only
suspected before. First, although a few genes are homologous to
known bacterial virulence factors that await experimental vali-
dation, the absence of genes encoding most classical virulence
factors was observed (Moreno and Moriyon 2002). These data
explain why Brucella was recently called a “nasty” (Moreno and
Moriyon 2002), “furtive” (Letesson et al. 2002), or even a
“stealthy” bug (Kohler et al. 2003). More importantly, these ge-
nomic sequences revealed the astonishing similarities between
Brucella (an intracellular pathogen of mammals) and Mesorhizo-
bium loti (a nitrogen fixing symbiont of plant) or Agrobacterium
tumefaciens (an extracellular plant pathogen).
Considering the available genomes of Brucellae, function has
been established by phenotypic or biochemical analysis for only
a minority (around 200) of the 3198 predicted genes identified
on their two chromosomes. Screens for transpositional mutants
attenuated in infection models yielded 184 mutants (Delrue et al.
2004), suggesting that these genes have a function in the infec-
tion process. Moreover, 688 genes correspond to what appears in
GenBank as hypothetical proteins, and most of them are con-
served in at least one other -Proteobacteria. Elucidation of the
pathogenic mechanisms used by Brucella and specific host–
pathogen interactions requires functional analysis of both Bru-
cella and eukaryotic host gene products. Therefore, our overall
objective is the large-scale analysis of protein function in Brucella sp.
The first step in that process is the cloning of a (nearly)
complete set of protein-encoding open reading frames (ORFs), or
“ORFeome” in a reusable and flexible recombinational cloning
system (Walhout et al. 2000b). Such an ORFeome should provide
a resource for systematic analysis of the molecular mechanisms
that enable Brucella to pursue its intracellular lifestyle within its
eukaryotic host. Because protein homology searches did yield
only a few effector candidates, functional genomic and pro-
teomic approaches should be applied to identify gene products
potentially involved in the interaction between the bacterium
and its host. The Brucella ORFeome is the platform to achieve this
objective. Additionally, the Brucella ORFeome might also contrib-
ute to a better understanding of related species such as -Proteo-
bacteria (LeVier et al. 2000; Briones et al. 2001; Lopez-Goni et al.
2002; Lestrate et al. 2003).
RESULTS
Primer Design
Prior to high-throughput (HT) ORFeome cloning, the overall
quality of the B. melitensis genome annotation was validated. In
particular, the most likely start codons of the 3198 predicted
ORFs were repredicted relative to the original genome annota-
tion (DelVecchio et al. 2002a), as their identification is crucial for
the various proteomic uses downstream of the ORFeome project.
Starting from the GenBank release of the B. melitensis 16M ge-
nome (NC_003317 and NC_003318 accession nos.; DelVecchio
et al. 2002a), a consortium of experts manually corrected the
predicted start codons of the previously annotated ORFs. A Web
site named the “Brucella melitensis database” containing various
types of information about the ORFs and their homologs was
constructed to allow such annotations (see Web sites references
for the URL). Briefly, start codons were corrected to have a pre-
dicted ribosome-binding site (RBS), allow typical operonic junc-
tion if applicable, and avoid extended overlaps with neighboring
ORFs. The close homology with proteins deduced from other
-Proteobacteria did often help to identify the most likely start
codon in the B. melitensis genome. Among the 3198 ORFs manu-
ally examined, 908 modifications of start codon prediction were
made, among which 565 ORFs were shortened, and 334 ORFs
were extended. There are 2223 ORFs preceded by a RBS (defined
as four bases of the AGGAGGU sequence, of which 1583 are
either AGGA, GGAG, GAGG, or AGGU) at positions 1 to 20
relative to the newly predicted start codon. The new annotated
sequences are available at the “Brucella melitensis database” (see
Web sites references).
To allow ORF cloning using the Gateway recombinational
system (Hartley et al. 2000; Walhout et al. 2000a), the attB1 and
attB2 sequences must be added during the PCR amplification, at
the 5 and 3 of each ORF, respectively. The attB1 and attB2
sequences were synthesized at the 5 end of each forward and
reverse primer, respectively. The last nucleotide of the stop
codon was not incorporated in the reverse primers, to allow C-
terminal fusion proteins to be expressed from Destination vec-
tors. The length of the ORF-specific sequence for each primer,
typically between 18 and 28 bases, was automatically determined
to obtain similar predicted annealing temperature for each pair
of primers. Half of all ORF-specific primer sequences were <21
nucleotides, due to the relatively high GC content of
B. melitensis ORFs (57.8% on average).
ORF Amplification
The overall scheme of the B. melitensis ORFeome cloning project
was based on the strategy used for the Caenorhabditis elegans
ORFeome (Reboul et al. 2003). All PCR amplification and cloning
steps were performed in 96-well plates using a “real-estate” that
organized ORFs according to increasing size and chromosome
location (Fig. 1).
From 3198 attempted amplifications, 3114 PCR products
could be detected by ethidium-bromide staining, suggesting a
97.4% success rate. Only a slight correlation was observed be-
tween PCR success rate and ORF size—1.3% of ORFs smaller than
1 kb failed to be amplified, and 4% of ORFs longer than 1 kb were
not amplified.
Gateway Cloning
PCR-amplified ORFs were inserted into the Gateway-compatible
vector pDONR201 by site-specific recombination. Gateway reac-
tions were performed in 96-well plates, even with the PCR prod-
ucts not visible after gel electrophoresis, as we have previously
obtained cloned ORFs from undetected amounts of amplicons
(Reboul et al. 2003). The resulting products were then introduced
into electrocompetent DH5-T1r Escherichia coli cells, again using
96-well plates, and the resulting bacterial transformants were se-
lected by growth in liquid medium containing kanamycin.
Evaluation of the turbidity of the culture suggested that transfor-
mants were absent in 54 wells of the 3198 tested, which yields a
98.3% success rate. Interestingly, transformants were obtained in
cases where PCR products were not detected by gel electropho-
resis. This confirms that low amounts of PCR fragments, unde-
tectable by ethidium bromide staining, can be sufficient for a
successful BP reaction. The expected ORFs were indeed present in
48 Entry clones generated with low amounts of PCR products (see
below). The content of wells A12, B12, C12, D12, and E12 of each
plate was spread on solid medium in order to estimate the num-
ber of transformants by reaction. Using these data, we estimate
that ∼80% of the transformant pools contain at least 50 clones,
that is, a sample of clones that represent both PCR-mutated and
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wild-type alleles of each ORF. Liquid cultures of transformant
pools were grown to generate glycerol stocks that constitute the
B. melitensis ORFeome library, version 1.1.
Validation of the Entry Clones
We verified the identity of the ORF inserted into each Entry clone
as follows. Plasmid DNA preparations were performed from the
3198 liquid cultures described in the previous section. These
preparations were used as template for a PCR reaction using
pDONR201-specific primers. These primers anneal on the
pDONR201 vector, in the attL1 and attL2 regions, and with their
3 end pointing toward the inserted ORF. This allows the ampli-
fication of the cloned insert along with ∼200 bp of flanking plas-
mid vector sequence. The identity of individual ORFs was con-
firmed by standard dideoxy sequencing reactions using these
PCR products as templates to generate ORF sequence tags (OSTs)
as described (Reboul et al. 2003). Individual OSTs were compared
with ORF sequences predicted from the B. melitensis genome se-
quences using the BLASTN program (Altschul et al. 1997). Suc-
cessful sequencing results were obtained for 2852 ORFs.
For the remaining ORFs, we utilized ORF-specific primers for
PCR amplification of the same PCR products used as templates
for the sequencing reactions. There were 239 amplifications that
gave the expected size product, which suggests that the expected
ORF is inserted in the corresponding Entry vector. Among the
107 missing ORFs, 36 failed the PCR amplification from genomic
DNA. Because all manipulations were done with pools of mol-
ecules (Reboul et al. 2003), there may be mixes of clones (includ-
ing vectors lacking the ORF of interest) for various transformants.
DISCUSSION
ORFeome v1.1 of B. melitensis is composed of 2852 ORFs, each
cloned as pools and confirmed by sequencing, and 239 addi-
tional entry clones, for which the presence of the expected ORF
was determined by PCR. Therefore, 3091 (96.7%) of the 3198 B.
melitensis ORFs are included in the ORFeome presented here. This
proportion of cloned ORFs is similar to
the one reported for the ORF collection
reported for Treponema pallidum (Mc-
Kevitt et al. 2003). This high-cloning ef-
ficiency compared with the C. elegans
ORFeome v1.1 (Reboul et al. 2003) is pri-
marily due to the fact that genomic
DNA, rather than a cDNA library, was
used for the PCR amplification step. At
this point, we do not know whether all
amplified and cloned ORFs are actually
expressed by B. melitensis under various
conditions, or whether some may actu-
ally represent pseudogenes.
Using the “pool” of Entry clones,
further versions of the ORFeome can be
generated that consist of isolated clones
that are free of mutations. Ongoing cor-
rections of the annotations of various
Brucella genomes may also yield new
ORFs to be included in the B. melitensis
ORFeome. Annotation is a real issue for
the generation of such ORFeome re-
sources, as a wrong start codon may
yield proteins inactive in functional as-
says as observed for the C. elegans
ORFeome version 1.1 (Reboul et al.
2003) and the main issue for generating
version 3.1 (Lamesch et al. 2004). Exten-
sive proteomic analyses could also be used to correct the genome
annotation, allowing the identification of previously undetected
coding sequences. To date, 232 individual proteins were identi-
fied using two-dimensional gel electrophoresis and mass spec-
trometry (DelVecchio et al. 2002b). In addition, sequencing of
other strains or species could lead to the discovery of new genes,
absent in B. melitensis, that could also be added to the B. meliten-
sis ORFeome to give a multispecies Brucella ORFeome. The Bru-
cella ORFeome should therefore be seen as a dynamic resource,
having various versions depending on the amount of ORFs, but
also on the presence in the library of clones validated as true
wild-type alleles by sequencing. Apart from the normalization of
individual clone abundance, the possibility to easily extend the
ORFeome library by including ORFs from different strains or spe-
cies is a major advantage of ORFeome libraries compared with
classical genomic libraries.
In the first step of this ORFeome project, we had to re-
evaluate the current start codons assignment (DelVecchio et al.
2002a). This allowed new analyses of the B. melitensis genomic
sequence, regarding the organization of coding sequences in op-
erons. As reported by Salgado et al. (2000) for E. coli, we observed
a high frequency of junctions within directons (i.e., several ORFs
pointing in the same orientation) ranging from 10 to +40 nt
(data not shown), suggesting that this distance could be used for
the prediction of operons. Using this criterion, we found 1392
ORFs organized in 537 operons. This number is probably an un-
derestimation, as long (>40 nt) junctions between ORFs can be
observed within operons, for example, between virB1 and virB2
coding sequences, in the B. suis virB operon (Boschiroli et al.
2002). During the correction of genome annotation, we also ob-
served that genomes of Brucella species sequenced to date are
closely related, as already suggested by Paulsen et al. (2002).
There are only 15 and 28 B. melitensis ORFs having no close
homolog in B. abortus and B. suis, respectively. Moreover, within
the Rhizobiales, the ORFs of B. melitensis, M. loti, A. tumefaciens,
and Sinorhizobium meliloti are closely related. There are 1802
ORFs conserved (E value lower than 1030 using the tBLASTN
Figure 1 Overview of the Brucella melitensis ORFeome construction. The main experimental steps of
the ORFeome construction, that is, PCR, BP cloning, transformation, and validation of the entry clones,
are shown in the top part of the figure. The success/failure distribution is given for the PCR, the
presence of transformants after BP reaction, and the validation of the entry clones. The success rates
are represented with hatched surfaces, whereas failure rates are shown in black. For the last step, the
additional portion (vertically hatched surface) corresponds to entry clones checked by PCR using
ORF-specific primers (see text for details). B1 and B2 stand for attB1 and attB2, respectively, and L1 and
L2 correspond to attL1 and attL2 sites, respectively.
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program) in all four genomes, whereas 2318 B. melitensis ORFs are
conserved in at least one of these bacteria. These data suggest
that Brucella could have emerged from a plant pathogen or sym-
biont, and raise the interesting possibility that some molecular
mechanisms involved in the interaction between the bacterium
and its host have been conserved (Inon de Iannino et al. 1998;
Sola-Landa et al. 1998).
As with the C. elegans ORFeome (Li et al. 2004), the B. meli-
tensis ORFeome is being used for protein–protein interaction
mapping studies. We have generated a two-hybrid interaction
matrix for the 41 proteins (1681 interactions tested, and 26 pro-
teins found to interact) putatively involved in the two-
component systems of Brucella (R. Hallez, M. Wéry, V. Van Mul-
lem, J. Vardenhaute, J.-J. Letesson, and X. DeBolle, unpubl.). Fur-
thermore, in the case of Brucella, it is not only important to
identify cognate protein–protein interactions, but also to identify
Brucella proteins that specifically interact with proteins from the
host. A complete analysis of this aspect of B. melitensis biology
awaits the construction of a mammalian ORFeome. It is very
likely that Brucella secretes effectors in the cytoplasm (and maybe
other subcellular locations) of infected cells, but these effectors
and their targets are presently unknown. However, the VirB se-
cretion system is essential for the virulence of this bacterium
(O’Callaghan et al. 1999). Thus, one way to identify virulence
effectors would be to screen for protein–protein interactions us-
ing either VirB proteins or predicted secretion chaperones as
baits, with both B. melitensis and human ORFeome clones as
preys.
The validation of protein–protein interactions detected us-
ing yeast or bacterial two-hybrid methods will also be facilitated
using the recombinational cloning from the ORFeome Entry vec-
tors. Vectors compatible with recombinational cloning and al-
lowing expression of ORFs as fusions with tags that can be used
for “medium-throughput” coimmunoprecipitation assays (Li et
al. 2004) will make confirmation of protein–protein interactions
straightforward.
Fusions with tags such as tandem affinity purification tags
could also allow the purification of stable complexes to identify
the partners involved (Rigaut et al. 1999). Protein tagging with
GFP may also be performed to localize protein at cell poles, such
as described for proteins involved in the control of cell cycle and
morphogenesis in Caulobacter crescentus, another -Proteobacte-
rium (Jacobs et al. 1999). Of further interest would be the sub-
cellular localization of proteins secreted by Brucella within the
host cell, such as with the membrane localization of YpkA from
Yersinia pseudotuberculosis (Hakansson et al. 1996) or the nuclear
localization of YopM from Y. pestis (Skrzypek et al. 1998). It is
expected that Brucella effectors could colocalize with markers of
compartments or membranes, such as the endoplasmic reticu-
lum or the endosomes. The introduction of Brucella ORFs into
eukaryotic (e.g., yeast) cells to find particular phenotypes associ-
ated with their expression (Lesser and Miller 2001) or to identify
effector proteins would be relatively easy to set up with an
ORFeome resource.
A further application of the ORFeome will be the generation
of low-cost DNA microarrays by amplification of the ORFs with a
single pair of primers, as all ORFs are inserted in the same vector.
The availability of the ORFeome will also allow high-
throughput recombinant protein production, using hosts such as
E. coli or yeast. We already know that Brucella ORFs can be ex-
pressed in yeast, as two-hybrid interactions may be observed
among two-component proteins. We also performed overexpres-
sion in E. coli from the ORFeome clones (R. Hallez, unpubl.).
These systems may be useful for antigen discovery, as demon-
strated for Treponema pallidum (McKevitt et al. 2003). The use of
appropriate purification tags would also allow various analyses,
including the systematic test of biochemical activities (Martzen
et al. 1999) and the detection of proteins able to interact with a
given ligand (Zhu et al. 2001). The evaluation of a large number
of proteins for their potential effect as protective antigens could
also be considered.
Another possible use for the ORFeome clones is the system-
atic mutagenesis of genes in the Brucella genome. Usually, gene
deletions are performed by a strategy of allelic replacement of the
target gene with an antibiotic resistance cassette. Using an anti-
biotic resistance cassette and a destination vector, each contain-
ing attR1 and attR2 sequences in the proper orientation, it
should, in principle, be possible to construct plasmids allowing
gene replacement by exchanging a given coding sequence with a
resistance gene. At the high-throughput level, it should therefore
be possible to delete each nonessential gene of the B. melitensis
genome. This strategy should also be effective for all bacteria in
which transformation and homologous recombination may be
applied. This systematic mutagenesis strategy would be interest-
ing, given the high bias found in the large-scale analysis of trans-
position mutants (Kohler et al. 2002).
In conclusion, the generation of a nearly complete
ORFeome for Brucella is a first and important step for undertaking
post-genomic approaches that will provide answers to the major
questions regarding the molecular mechanisms of virulence, par-
ticularly regarding the interactions between these bacteria and
their hosts. It is expected that these mechanisms may be con-
served in other -Proteobacteria, as they may adopt similar mo-
lecular strategies to interact with a eukaryotic host.
METHODS
Correction of the Annotations of the
B. melitensis Genome
The annotated genome files of B. melitensis (named
NC_003318.gbk and NC_003317.gbk for the large and small
chromosomes, respectively) were downloaded directly from the
NCBI ftp site (ftp://ftp.ncbi.nih.gov/genomes/Bacteria/). The Ar-
temis free software, obtained from the Sanger Artemis Web site
(http://www.sanger.ac.uk/Software/Artemis/), was used to local-
ize annotations.
For each ORF, we manually checked the predicted start
codons using Artemis for sequence examination. The following
criteria were used to predict likely start codons. The AUG start
codon was preferred to GUG, which itself was preferred to UUG.
Typical operonic junctions in which stop codon of the preceding
ORF was fused either in the 1 or 4 position (Salgado et al.
2000) to the start codon of the next ORF of an operon were
frequently observed and used to locate likely start codons inside
operons. The predicted start codons should present an obvious
ribosome-binding site (RBS), usually AGGA, GGAG, or GAGG at
positions 5 to 20. When close homologs of an ORF were
detected, the start codon corresponding to the size of the closest
homologs was chosen. If an ORF was shorter than its homologs,
and if similarity was detectable by extending the ORF in the same
frame, a new start site was searched. In the absence of any ho-
molog, and in the absence of obvious RBS, the longest ORF start-
ing with an AUG or GUG start codon was predicted. The Brucella
melitensis database Web site was used to compare the deduced
N-terminal peptidic sequence with those of homologous se-
quences, if any. The comments were incorporated at the Brucella
melitensis database Web site and further processed to give a new
version of the annotated genome, available in the GenBank for-
mat. The set of 3198 protein-coding ORFs was extracted from the
corrected version of the annotated genome.
Primer Design
The attB1 segment (5-GGGGACAAGTTTGTACAAAAAAG
CAGGC-3) was added before the start codon of each forward
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primer, followed by ORF-specific bases (see below). The attB2
segment (5-GGGGACCACTTTGTACAAGAAAGCTGGG-3) was
added at the 5 end of each reverse primer, which was comple-
mentary to the end of the ORF, without the last nucleotide of the
stop codon, as previously described (Walhout et al. 2000b; Re-
boul et al. 2003). The size (typically 18 to 28 bases) of the forward
and reverse primer parts that are complementary to the ORF were
determined to give a similar annealing temperature during the
PCR, usually in the range of from 60 to 70°C. The primers were
obtained from Illumina Inc. in a 96-well format, and in each
plate, the G12 and H12 wells were left empty to incorporate
controls (see below).
PCR Amplification of the ORFs
Each PCR reaction was performed in a 50-µL volume, with 1 unit
of Platinum HiFi polymerase (Invitrogen), MgSO4 2 mM, dNTP
mix (0.2 mM each), forward and reverse primers (0.125 µM each)
and genomic DNA (75 ng). The B. melitensis DNA was a kind gift
of C. Baldwin laboratory (University of Massachusetts, Amherst).
The 25 PCR cycles (94°C for 45 sec, 56°C for 1 min, and 68°C for
1 min/kb) were preceded by heating to 94°C for 2 min, and were
followed by a 5-min incubation at 68°C. Confirmation and size
of the PCR products was determined by agarose gel electropho-
resis using E-gels (Invitrogen).
BP Cloning Reaction of the Amplified ORFs
The BP reactions were performed in 96-well plates using the In-
vitrogen BP kit, in a final volume of 10 µL containing 2 µL of
unpurified PCR product, 75 ng of pDONR201 plasmid (Invitro-
gen), and 1.5 µL of BP clonase. In each 96-well plate, the G12 well
was empty (see below) and the H12 well contained a BP reaction
mix without PCR product, to evaluate the background given by
the BP reaction. The BP reactions were incubated overnight at
25°C and then stored at 20°C or used directly for bacterial
transformation.
Transformation and Plasmid Preparation
In 96-well plates, individual bacterial transformations were car-
ried out using 20 µL of DH5-T1r Max Efficiency competent cells
(Invitrogen), 2 µL of the BP reaction products, and 105 µL of SOC
medium. After the transformation reaction, 120 µL of E. coli
transformants were transferred to 96-deep well plates (QIAGEN)
containing 800 µL of LB with kanamycin (50 µg/mL) using a
GenMate robot (Tecan). In each 96-well plate, the G12 well con-
tained a pUC19 vector (2 pg) as positive control of transforma-
tion, and the H12 well (containing BP reaction mixes without
PCR product) were used as negative control. The transformation
mixes of G12 and H12 wells were plated on solid medium supple-
mented with the appropriated antibiotic (ampicillin, 50 µg/mL
for G12 wells, and kanamycin, 50 µg/mL for H12 wells).
After overnight growth at 37°C, 50 µL of each culture was
reserved for glycerol stocks and the remaining culture was pro-
cessed for automated plasmid preparations with a QIAGEN
BioRobot 9600.
Test of the Entry Clones
To identify and confirm all ORF entry clones, we performed PCR,
followed by sequencing of the PCR product. The PCR was per-
formed as above, except that 2 µL of the plasmid preparation was
used as template and universal primers (0.38 µM each) flanking
the ORF (5-TCGCGTTAACGCTAGCATGGATCTC-3) and (5-
GTAACATCAGAGAGATTTTGAGACAC-3) were used. The same
universal primers were also used for standard dideoxy sequencing
reactions as described (Reboul et al. 2003). When sequencing
data was not satisfactory, a PCR with ORF-specific primers de-
scribed above was performed, using the conditions employed for
initial amplification of the ORF from genomic DNA.
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